Contemporary Endovascular Treatment of Femoropopliteal Disease: Lesion Preparation, Antiproliferative Therapies, and Emerging Technologies

Background

Endovascular treatment of femoropopliteal atherosclerotic disease has evolved from plain balloon angioplasty and routine stenting toward lesion-oriented strategies that combine plaque assessment, selective vessel preparation, antiproliferative drug delivery, and provisional scaffolding. The increasing availability of drug-coated balloons, drug-eluting stents, atherectomy, intravascular lithotripsy, intravascular imaging, and sirolimus-based technologies has improved therapeutic options but has also made device selection more complex.